Top compounds associated with response to TMEM136


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CCLE pan-cancer AAC -0.2 2e-06
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA Erlotinib CCLE pan-cancer AAC -0.2 2e-05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA lapatinib CCLE pan-cancer AAC -0.19 6e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 9e-05
mRNA YM-155 CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
Download CSV